Inaugural NHMRC Centre of Excellence in Primary Aldosteronism Symposium
Practice Pearls and Clinical Updates in Primary Aldosteronism
Wednesday 13th November 2024
Times are subject to change*
The NHMRC Centre of Research Excellence invites you to attend the inaugural Primary Aldosteronism Symposium.
Experts in the field will share their practice pearls and research updates in the diagnosis and management of primary aldosteronism, the most common endocrine cause of hypertension.
Please join us for an afternoon of immersive learning!
Sponsored by:
Symposium Attendee
What your registration includes:
Catered Lunch
Catered afternoon tea
Access to all sessions
Early Bird
$150.00
Regular
$170.00
Virtual
$100.00
-
Applications open: 8 April 2024
Application deadline: 16 September 2024
Conditions of award
The purpose of this award is to provide financial support to PhD students and Early Career Researchers to attend the Inaugural NHMRC Centre of Excellence in Primary Aldosteronism Symposium on Wednesday 13th November 2024 in Adelaide, Australia (Primary Aldosteronism Symposium — ESA-SRB-ANZBMS 2024).
Several awards of $500 each will be granted to assist with Symposium-related travel and expenses. Symposium registration will be complimentary for successful applicants.
Travel to the Symposium must occur in the year of application.
Eligibility
Applicants must be PhD students or Early Career Researchers (within 5 years of being awarded of their PhD, recognising career disruptions) with evidence of research interests in Primary Aldosteronism.
Application
Applications must include the following documentation:
• A cover letter outlining reason for the application, research interests in Primary Aldosteronism and intended benefits of Symposium attendance (max 1 A4 page).
• A short CV (max 2 A4 pages) highlighting a list of publications, research funding, conferences, professional contributions and career disruptions (if relevant) in the last five years.
• A letter of support from the PhD supervisor or Post-doctoral Advisor discussing the merits of the applicant (max 1 A4 page).
All applications should be a single, combined PDF file and named as follows:
PACE Travel Grant_2024_Full Name.pdf e.g. PACE Travel Grant_2024_John Smith.pdf.
Please note, you will need to have/create a google account in order to apply for the grant. This can be created during the application process.
Selection
Applications will be assessed by a Selection Committee appointed by the Symposium Convenors.
The Selection Committee has a duty to apply the criteria equitably to all applicants. Applicants will be assessed on the basis of their cover letter, supporting letter and CV.
Successful applicants will be notified by email by mid-October 2024.
Presentation
Recipients must acknowledge the financial support of PACE when presenting their work.
Speakers
Prof Michael Stowasser, University of Queensland
Dr Richard Carroll, New Zealand Society of Endocrinology
Prof Peter Fuller, Monash Health
Dr Renata Libianto, Hudson Institute of Medical Research
Dr Moe Thuzar, University of Queensland
Dr Andrea Horvath, Prince of Wales Hospital
Associate Professor Damon Bell, University of Western Australia
Associate Professor Cherie Chiang, Melbourne Health, Austin Health and Peter MacCallum Cancer Centre
Dr Jimmy Shen, Monash Health
Prof Trevor Mori, University of Western Australia, Perth, WA
Program
1:00PM – 1:40PM LUNCH
1.40PM – 2.00PM | Introduction to PACE
Professor Peter Fuller
Hudson Institute of Medical Research, Clayton, VIC
2:00PM – 3:15PM | Primary Aldosteronism Practice Pearls Session
Chair: A/Professor Jun Yang
Hudson Institute of Medical Research, Clayton, VIC
Primary Aldosteronism Case Identification: who, when, how? – Dr Jimmy Shen
Monash Health, Clayton, VICConfirmatory testing: what to do with discordant or borderline results?
A/Professor Cherie Chiang
Royal Melbourne Hospital and University of Melbourne, Melbourne, VICTricky Adrenal Venous Sampling results and interpretation A/Professor Damon Bell
Royal Perth Hospital, Perth, WADoes everyone need Adrenal Venous Sampling? Other strategies for subtyping
Professor Michael Stowasser
Princess Alexandra Hospital, Brisbane, QLDQuestion and Answer Panel
3.15PM – 3.45PM | AFTERNOON TEA
3.45PM – 5.00 PM | Primary Aldosteronism Clinical Update session
Chair: Professor Michael Stowasser
Lived experience panel – hosted by A/Professor Jun Yang
Development of steroid profiling for Primary Aldosteronism diagnosis
Professor Rita Horvath
NSW Pathology, Sydney, NSWMonitoring the outcomes of surgical and medical treatment
Dr Renata Libianto
Hudson Institute of Medical Research, Clayton, VICMetanephrines in Adrenal Venous Sampling
Dr Richard Carroll
Te Whatu Ora Health New Zealand Capital, Coast and Hutt Valley, Wellington, New ZealandAldosterone, renin and cardiovascular parameters in the Raine Study
Professor Trevor Mori
University of Western Australia, Perth, WACardiometabolic health in Primary Aldosteronism
Dr Moe Thuzar
Princess Alexandra Hospital, Brisbane, QLD5:00PM – 5:10 PM Closing Remarks
Professor Peter Fuller
Co-convenors
Professor Peter Fuller
Endocrinology Unit, Monash Health and Centre for Endocrinology and Metabolism, Hudson Institute
A/Professor Jun Yang
Head, Endocrine Hypertension Group, Hudson Institute of Medical Research
Professor Michael Stowasser
Director, Endocrine Hypertension Research Centre, University of Queensland Frazer Institute